Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Guided Therapeutics, Inc.

Market Cap 1.96Cr 1.69Cr 1.56Cr 1.46Cr 2.73Cr 186.04Cr 2.78Cr 18Cr 7.17Cr 91Cr 7.35Cr 7.19Cr 313.54Cr P/E Ratio 2024
-3x
P/E Ratio 2025 -12.7x
Enterprise Value 2.24Cr 1.94Cr 1.79Cr 1.67Cr 3.13Cr 213.38Cr 3.18Cr 21Cr 8.23Cr 103.86Cr 8.43Cr 8.25Cr 359.61Cr EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
1 day+1.38%
1 week+1.40%
Current month-11.44%
1 month+1.40%
3 months-30.07%
6 months-24.89%
Current year-62.44%
1 week 0.18
Extreme 0.1805
0.2
1 month 0.18
Extreme 0.18
0.23
Current year 0.17
Extreme 0.17
0.54
1 year 0.12
Extreme 0.1231
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
9,280
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 70 01/12/2016
Director/Board Member 76 10/04/2006
Chairman 67 01/10/2013
Date Insider Type Main position Quantity % Market Cap.
10/03Free

Director

1,10,000 0.1316%
10/03Others

Director

10 0.9747%
10/03Free

Chairman

1,10,000 0.1316%
Change 5-day change 1-year change 3-year change Capi.($)
+1.38%+1.40%+6.74%+23.36% 1.96Cr
-1.33%-0.73%+13.00%-10.38% 17TCr
-0.45%-2.61%-19.87%+31.06% 15TCr
-0.38%-2.28%-12.19%-24.34% 13TCr
-0.55%-3.38%-52.40%-8.38% 6.97TCr
-0.76%-0.99%+12.15%-0.54% 4.9TCr
+0.67%-0.60%-25.38%-34.31% 4.47TCr
+0.22%-4.13%+9.19%+9.53% 3.67TCr
-1.17%-2.69%+1.70%+38.38% 3.49TCr
+1.04%+0.79%-10.85%-16.72% 2.96TCr
Average -0.13%-1.89%-7.79%+0.77% 7.12TCr
Weighted average by Cap. -0.55%-1.98%-8.84%-1.89%

Financials

2024 2025
Net sales 7T 6.05T 5.57T 5.22T 9.77T 7L 9.92T 65.78T 25.65T 3L 26.27T 25.71T 11.21L 8L 7L 6L 6L 10.71L 7.29Cr 10.87L 72.08L 28.1L 3.55Cr 28.79L 28.17L 12Cr
Net income -24.17L -20.88L -19.24L -18.01L -33.75L -23Cr -34.27L -2.27Cr -88.56L -11Cr -90.71L -88.78L -39Cr -31.96L -27.6L -25.44L -23.81L -44.62L -30Cr -45.31L -3Cr -1.17Cr -15Cr -1.2Cr -1.17Cr -51Cr
Net Debt 17.71L 15.3L 14.1L 13.19L 24.73L 17Cr 25.11L 1.66Cr 64.89L 8.19Cr 66.47L 65.05L 28Cr 28.76L 24.84L 22.89L 21.43L 40.15L 27Cr 40.78L 2.7Cr 1.05Cr 13Cr 1.08Cr 1.06Cr 46Cr
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
10/26/10 0.2028 $ +1.38% 2,919
05/26/05 0.2000 $ -12.28% 11,300
  1. Stock Market
  2. Stocks
  3. GTHP Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!